With William R. Boudreaux, Joshua E. Ney, Ph.D.
The Patent Trial and Appeal Board ("PTAB") recently sided with petitioner BioMarin Pharmaceutical in three inter partes review proceedings involving Genzyme’s enzyme therapy product Myozyme®.